Talus osteochondritis dissecans: Treatment with matrix-based autologous chondrocyte implantation

Eric Giza, Ryan Nathe, Jason Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Osteochondral lesions of the talus are a common occurrence especially in sports, occurring 6.5% of all ankle sprains. Inherently talar cartilage is unable to repair itself secondary to the lack of blood supply, and it is incapable of healing through the typical inflammatory phase. Such damage can be irreversible and lead to the onset of osteoarthritis. There are many surgical repair options for osteochondral lesion of the talus. However, a trial of conservative therapy is warranted especially because studies have shown that this does not adversely affect the outcome of the surgery. Ideally, the treatment options should focus on restoring the articular cartilage surface, normal hyaline cartridge, and improvement of patients symptoms and function. Conventional surgical techniques, such as drilling and microfractures, try to address these goals through bone stimulation. However, these reparative techniques form disorganized fibrocartilage regenerate, which lacks the durability and many of the mechanical properties of the hyaline cartilage that normally covers the articular surfaces. In addition, poorer outcomes have been associated with lesions that are larger than 1 cm. There have been recent advances in surgical techniques to address these issues. The autologous chondrocyte implantation and matrix-based chondrocyte implantation use cells that are harvested from the body for the repair of chondral defect. These biological approaches for the treatment of chondral defects of the talus are introduced here.

Original languageEnglish (US)
Pages (from-to)231-236
Number of pages6
JournalTechniques in Orthopaedics
Volume25
Issue number4
DOIs
StatePublished - Dec 2010

Fingerprint

Osteochondritis Dissecans
Talus
Chondrocytes
Cartilage
Fibrocartilage
Hyaline Cartilage
Ankle Injuries
Stress Fractures
Hyalin
Articular Cartilage
Osteoarthritis
Sports
Therapeutics
Joints
Bone and Bones

Keywords

  • autologous chondrocyte implantation
  • implantation
  • matrix-based chondrocyte
  • osteochondral lesion
  • osteochondritis dissecans
  • talus

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Talus osteochondritis dissecans : Treatment with matrix-based autologous chondrocyte implantation. / Giza, Eric; Nathe, Ryan; Kim, Jason.

In: Techniques in Orthopaedics, Vol. 25, No. 4, 12.2010, p. 231-236.

Research output: Contribution to journalArticle

@article{6ed63b23aec24a589096694e246dd49c,
title = "Talus osteochondritis dissecans: Treatment with matrix-based autologous chondrocyte implantation",
abstract = "Osteochondral lesions of the talus are a common occurrence especially in sports, occurring 6.5{\%} of all ankle sprains. Inherently talar cartilage is unable to repair itself secondary to the lack of blood supply, and it is incapable of healing through the typical inflammatory phase. Such damage can be irreversible and lead to the onset of osteoarthritis. There are many surgical repair options for osteochondral lesion of the talus. However, a trial of conservative therapy is warranted especially because studies have shown that this does not adversely affect the outcome of the surgery. Ideally, the treatment options should focus on restoring the articular cartilage surface, normal hyaline cartridge, and improvement of patients symptoms and function. Conventional surgical techniques, such as drilling and microfractures, try to address these goals through bone stimulation. However, these reparative techniques form disorganized fibrocartilage regenerate, which lacks the durability and many of the mechanical properties of the hyaline cartilage that normally covers the articular surfaces. In addition, poorer outcomes have been associated with lesions that are larger than 1 cm. There have been recent advances in surgical techniques to address these issues. The autologous chondrocyte implantation and matrix-based chondrocyte implantation use cells that are harvested from the body for the repair of chondral defect. These biological approaches for the treatment of chondral defects of the talus are introduced here.",
keywords = "autologous chondrocyte implantation, implantation, matrix-based chondrocyte, osteochondral lesion, osteochondritis dissecans, talus",
author = "Eric Giza and Ryan Nathe and Jason Kim",
year = "2010",
month = "12",
doi = "10.1097/BTO.0b013e31820105d4",
language = "English (US)",
volume = "25",
pages = "231--236",
journal = "Techniques in Orthopaedics",
issn = "0885-9698",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Talus osteochondritis dissecans

T2 - Treatment with matrix-based autologous chondrocyte implantation

AU - Giza, Eric

AU - Nathe, Ryan

AU - Kim, Jason

PY - 2010/12

Y1 - 2010/12

N2 - Osteochondral lesions of the talus are a common occurrence especially in sports, occurring 6.5% of all ankle sprains. Inherently talar cartilage is unable to repair itself secondary to the lack of blood supply, and it is incapable of healing through the typical inflammatory phase. Such damage can be irreversible and lead to the onset of osteoarthritis. There are many surgical repair options for osteochondral lesion of the talus. However, a trial of conservative therapy is warranted especially because studies have shown that this does not adversely affect the outcome of the surgery. Ideally, the treatment options should focus on restoring the articular cartilage surface, normal hyaline cartridge, and improvement of patients symptoms and function. Conventional surgical techniques, such as drilling and microfractures, try to address these goals through bone stimulation. However, these reparative techniques form disorganized fibrocartilage regenerate, which lacks the durability and many of the mechanical properties of the hyaline cartilage that normally covers the articular surfaces. In addition, poorer outcomes have been associated with lesions that are larger than 1 cm. There have been recent advances in surgical techniques to address these issues. The autologous chondrocyte implantation and matrix-based chondrocyte implantation use cells that are harvested from the body for the repair of chondral defect. These biological approaches for the treatment of chondral defects of the talus are introduced here.

AB - Osteochondral lesions of the talus are a common occurrence especially in sports, occurring 6.5% of all ankle sprains. Inherently talar cartilage is unable to repair itself secondary to the lack of blood supply, and it is incapable of healing through the typical inflammatory phase. Such damage can be irreversible and lead to the onset of osteoarthritis. There are many surgical repair options for osteochondral lesion of the talus. However, a trial of conservative therapy is warranted especially because studies have shown that this does not adversely affect the outcome of the surgery. Ideally, the treatment options should focus on restoring the articular cartilage surface, normal hyaline cartridge, and improvement of patients symptoms and function. Conventional surgical techniques, such as drilling and microfractures, try to address these goals through bone stimulation. However, these reparative techniques form disorganized fibrocartilage regenerate, which lacks the durability and many of the mechanical properties of the hyaline cartilage that normally covers the articular surfaces. In addition, poorer outcomes have been associated with lesions that are larger than 1 cm. There have been recent advances in surgical techniques to address these issues. The autologous chondrocyte implantation and matrix-based chondrocyte implantation use cells that are harvested from the body for the repair of chondral defect. These biological approaches for the treatment of chondral defects of the talus are introduced here.

KW - autologous chondrocyte implantation

KW - implantation

KW - matrix-based chondrocyte

KW - osteochondral lesion

KW - osteochondritis dissecans

KW - talus

UR - http://www.scopus.com/inward/record.url?scp=78650486429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650486429&partnerID=8YFLogxK

U2 - 10.1097/BTO.0b013e31820105d4

DO - 10.1097/BTO.0b013e31820105d4

M3 - Article

AN - SCOPUS:78650486429

VL - 25

SP - 231

EP - 236

JO - Techniques in Orthopaedics

JF - Techniques in Orthopaedics

SN - 0885-9698

IS - 4

ER -